Passions

Weightlifting and powerlifting

Violin

Cooking

Experience

Cooley Wins at the PTAB for NeuroDerm

November 1, 2023

Cooley is representing NeuroDerm and its parent company, Mitsubishi Tanabe Pharma Corp., in a post-grant review challenging an AbbVie patent related to methods of continuous subcutaneous treatment of Parkinson’s disease. After a hearing in October 2023, the US Patent Trial and Appeal Board issued a final written decision finding all claims of AbbVie’s patent unpatentable.

NeuroDerm and AbbVie are both seeking regulatory approval in the US for continuous subcutaneous treatments for Parkinson’s disease, and AbbVie’s patent effectively attempted to claim all successful methods of such treatment. Lawyers Geoff Biegler and Mark Weinstein are leading the team representing NeuroDerm with assistance from associates, Bonnie Fletcher Price and Andrew Lau.

Related contacts

Geoffrey Biegler
Partner, San Diego
Mark Weinstein
Partner, Palo Alto
Andrew Lau
Associate, Palo Alto

Related Practices & Industries

Admissions and credentials

California

Memberships and affiliations

The State Bar of California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.